Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma

Ovarian clear cell carcinoma (OCCC) is a subtype of epithelial ovarian cancer (EOC) that is associated with elevated interleukin-6 (IL-6) expression, resistance to chemotherapy, and increased mortality. Although bevacizumab (Bev) is a widely used anti-angiogenic agent for EOC, the efficacy of Bev an...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Sci Rep
Huvudupphovsmän: Seki, Toshiyuki, Yanaihara, Nozomu, Shapiro, Jason Solomon, Saito, Misato, Tabata, Junya, Yokomizo, Ryo, Noguchi, Daito, Kuroda, Takafumi, Kawabata, Ayako, Suzuki, Jiro, Takahashi, Kazuaki, Matsuzawa, Haruka, Miyake, Misayo, Takenaka, Masataka, Iida, Yasushi, Yanagida, Satoshi, Okamoto, Aikou
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group UK 2021
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8032732/
https://ncbi.nlm.nih.gov/pubmed/33833265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-86913-9
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk